Search Results1-9 of  9

  • 小室 昌仁 ID: 9000000636642

    大鵬薬品・代謝分析研 (2001 from CiNii)

    Articles in CiNii:2

    • 門脈 - 体循環血濃度差法によるイヌ小腸及び肝の初回通過効果 (2001)
    • TAS-102経口投与におけるヒトFTD代謝の予測 (2001)
  • 小室 昌仁 ID: 9000001070002

    大鵬薬品工業株式会社 (2002 from CiNii)

    Articles in CiNii:1

    • 新規H_2受容体拮抗剤ラフチジンの透析患者における体内動態の検討 (2002)
  • Komuro Masahito ID: 9000256184175

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1994 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic study of tazobactam/piperacillin in liver or kidney injury rabbits or pediatric dogs (1994)
  • Komuro Masahito ID: 9000256184182

    Pharmacokinetics Research Laboratory Taiho Pharmaceutical Co., Ltd. (1994 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic study of tazobactam/piperacillin in experimental animals (1994)
  • Komuro Masahito ID: 9000256184185

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1994 from CiNii)

    Articles in CiNii:1

    • Studies on metabolism of tazobactam/piperacillin in some animals (1994)
  • Komuro Masahito ID: 9000256184189

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd. (1994 from CiNii)

    Articles in CiNii:1

    • Distribution and excretion of <SUP>14</SUP>C-labeled tazobactam/piperacillin in rats (1994)
  • Komuro Masahito ID: 9000283798219

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical CO., LTD. (2008 from CiNii)

    Articles in CiNii:1

    • PHARMACOKINETIC PROFILES OF LAFUTIDINE IN PATIENTS WITH CHRONIC HEPATIC IMPAIRMENT (2008)
  • Komuro Masahito ID: 9000283798640

    TAIHO PHARMACEUTICAL CO., LTD (2008 from CiNii)

    Articles in CiNii:1

    • INVOLVEMENT OF CONCENTRATIVE NUCLEOSIDE TRANSPORTERS (CNTS) IN INTESTINAL ABSORPTION OF FTD, A NOVEL ANTITUMOR NUCLEOSIDE, IN RATS (2008)
  • Komuro Masahito ID: 9000347046987

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical CO., LTD. (2006 from CiNii)

    Articles in CiNii:1

    • ESTIMATION OF THE ELIMINATION PATHWAY OF OTERACIL POTASSIUM IN HUMAN (2006)
Page Top